Additionally, RIPK3 expression is decreased in malignancies in IBD patients, which subsequently demonstrates that RIPK3 expression is downregulated in human CRC and is associated with the development of cancer [93]. This evidence concerns the gene RIPK3 and inflammatory bowel disease.